Literature DB >> 22300712

Sex steroids in Sjögren's syndrome.

Yrjö T Konttinen1, Georg Fuellen, Yan Bing, Pauliina Porola, Vasily Stegaev, Nina Trokovic, Steffi S I Falk, Yi Liu, Peter Szodoray, Yuya Takakubo.   

Abstract

The purpose of the review is to consider pathomechanisms of Sjögren's syndrome (SS), which could explain the female dominance (9:1), the most common age of onset (40-50 years) and targeting of the exocrine glands. Estrogens seem to specifically protect secretory glandular acinar cells against apoptosis whereas lack of estrogens during menopause and climacterium specifically leads to increased apoptosis of the exocrine secretory cells. Male gonads produce testosterone and convert it in exocrine glands to dihydrotesterosterone (DHT), which is anti-apoptotic and protects against acinar cell apoptosis. Estrogen-deficient women need to produce dehydroepiandrosterone (DHEA) in the adrenal glands and convert it to DHT in exocrine glands in a complex and branching reaction network in which individual enzymatic reactions are catalyzed in forward and backward directions by a myriad of different isoforms of steroidogenic enzymes. Tailoring DHT in peripheral tissues is much more complex and vulnerable in women than in men. In SS the intracrine steroidogenic enzyme machinery is deranged. These endo-/intracrine changes impair acinar remodeling due to impaired integrin α1β1 and integrin α2β1 expression so that the intercalated duct progenitor cells are unable to migrate to the acinar space, to differentiate to secretory acinar cells upon contact with laminin-111 and laminin-211 specifically found in the acinar basement membrane. The disarranged endo-/intracrine estrogen/androgen balance induces acinar cells to release microparticles and apoptotic bodies and to undergo apoptotis and/or anoikis. Membrane particles contain potential autoantigens recognized by T- (TCRs) and B-cell receptors (BCRs) and danger-associated molecular patterns (DAMPs) recognized by Toll-like receptors (TLRs). In membrane particles (or carrier-complexes) antigen/adjuvant complexes could stimulate professional antigen capturing, processing and presenting cells, which can initiate auto-inflammatory and autoimmune cascades, break the self-tolerance and finally lead to SS.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22300712     DOI: 10.1016/j.jaut.2012.01.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  21 in total

Review 1.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

2.  Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjögren's syndrome.

Authors:  M Ainola; P Porola; Y Takakubo; B Przybyla; V P Kouri; T A Tolvanen; A Hänninen; D C Nordström
Journal:  Clin Exp Immunol       Date:  2017-11-28       Impact factor: 4.330

Review 3.  Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.

Authors:  Marjan Farid; Anshu Agrawal; Daniel Fremgen; Jeremiah Tao; He Chuyi; Anthony B Nesburn; Lbachir BenMohamed
Journal:  Ocul Immunol Inflamm       Date:  2014-12-23       Impact factor: 3.070

4.  No male predominance in offspring of women with rheumatoid arthritis or systemic lupus erythematosus.

Authors:  Lior Dar; Varda Shalev; Dahlia Weitzman; Gabriel Chodick; Yoav Arnson; Howard Amital
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

5.  Risk of Sjögren's syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case-control study.

Authors:  Ming-Chi Lu; Min-Chih Hsieh; Malcolm Koo; Ning-Sheng Lai
Journal:  Rheumatol Int       Date:  2015-07-21       Impact factor: 2.631

Review 6.  Menopause and Rheumatic Disease.

Authors:  Mitali Talsania; Robert Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2017-05       Impact factor: 2.670

7.  Diffuse Cystic Lung Disease as the Presenting Manifestation of Sjögren Syndrome.

Authors:  Nishant Gupta; Kathryn A Wikenheiser-Brokamp; Aryeh Fischer; Francis X McCormack
Journal:  Ann Am Thorac Soc       Date:  2016-03

8.  Does estrogen deficiency cause lacrimal gland inflammation and aqueous-deficient dry eye in mice?

Authors:  Raheleh Rahimi Darabad; Tomo Suzuki; Stephen M Richards; Frederick A Jakobiec; Fouad R Zakka; Stefano Barabino; David A Sullivan
Journal:  Exp Eye Res       Date:  2014-07-30       Impact factor: 3.467

9.  Identification of susceptibility gene associated with female primary Sjögren's syndrome in Han Chinese by genome-wide association study.

Authors:  I-Wen Song; Hsiang-Cheng Chen; Yuh-Feng Lin; Jenn-Hwai Yang; Chi-Ching Chang; Chung-Tei Chou; Ming-Ta Michael Lee; Yi-Chun Chou; Chien-Hsiun Chen; Yuan-Tsong Chen; Chen-Hung Chen; Jer-Yuarn Wu
Journal:  Hum Genet       Date:  2016-08-08       Impact factor: 4.132

10.  Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis.

Authors:  V Hauk; L Fraccaroli; E Grasso; A Eimon; R Ramhorst; O Hubscher; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.